Pilot Neoadjuvant Trial of Chemohormonal Therapy Followed by Prostatectomy in Patients With High Risk or Oligometastatic Prostate Cancer
Phase of Trial: Phase 0
Latest Information Update: 19 May 2018
At a glance
- Drugs Bicalutamide (Primary) ; Degarelix (Primary) ; Docetaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Apr 2018 Status changed from suspended to recruiting.
- 12 Apr 2018 Status changed from recruiting to suspended due to Resources.